Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man

European Journal of Oral Sciences

Volumn 109, Issue 6, 2001, Pages 371-374

  Hedner, Ewa ^a   Birkhed, Dowen ^b   Hedner, Jan ^b   Ekström, Jörgen ^b   Helander, Herbert F ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dry mouth; Minor salivary glands; Physostigmine; Saliva stimulation

Indexed keywords

CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; MINOR SALIVA GLAND; MOUTH MUCOSA; NONPARAMETRIC TEST; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SECRETION; STIMULATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANALYSIS OF VARIANCE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; PHYSOSTIGMINE; SALIVARY GLANDS, MINOR; SALIVATION; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL;

EID: 0035654490     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1034/j.1600-0722.2001.00129.x     Document Type: Article

References (19)

1. NEDERFORS T, ISAKSSON R, MÖRNSTAD H, DAHLÖF C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population - relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 1997; 25: 211-216.
2. ÖSTERBERG T, LANDAHL S, HEDEGÅRD B. Salivary flow, saliva pH and buffering capacity in 70-yr-old men and women. J Oral Rehab 1984; 11: 157-170.
3. SREEBNY LM, BROICH G. Xerostomia (dry mouth). In: SREEBNY LM, ed. The salivary system. Boca Raton, FL: CRC Press, 1988; 179-202.
4. WISEMAN LR, FAULDS D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995; 49: 143-155.
5. HEINTZE U, BIRKHED D, BJÖRN H. Secretion rate and buffer effect on resting and stimulated whole saliva as a function of age and sex. Swed Dent J 1983; 7: 227-238.
6. ELIASSON L, BIRKHED D, HEYDEN G, STRÖMBERG N. Studies on human minor salivary gland secretions using the Periotron method. Arch Oral Biol 1996; 41: 1179-1182.
7. HEROLD ML, CONSTANZER ML, MATUSZEWSKI BK. Determination of picogram levels of heptylphysostigmine in human plasma using high-performance liquid chromatography with fluorescence detection. J Chromatogr 1992; 581: 227-236.
8. ROSSINI RB, MACHADO AB, MACHADO CRS. A histochemical study of catecholamines and cholinesterases in the autonomic nerves of the human minor salivary glands. Histochem J 1979; 11: 661-668.
9. HARTVIG P, WIKLUND L, AQUILONIUS SM, LINDSTRÖM B. Clinical pharmacokinetics of acetylcholinesterase inhibitors. In: AQUILONIUS SM, GILLBERG PG, eds. Progress in brain research. Vol. 84. Amsterdam: Elsevier, 1990; 139-143.
10. WALTER K, MÜLLER M, BARKWORTH MF, NIECIECKI AV, STANISLAUS F. Pharmacokinetics of physostigmine in man following a single application of a transdermal system. Br J Clin Pharmacol 1995; 39: 59-63.
11. WHELPTON R, HURST P. Bioavailability of oral physostigmine. New Engl J Med 1985; 313: 1293-1294.
12. SHERN RJ, Fox PC, LI SH. Influence of age on the secretory rates of the human minor salivary glands and whole saliva. Arch Oral Biol 1993; 38: 755-761.
13. NIEDERMEYER W. Physiologie and Pathophysiologie der kleinen Speicheldrüsen. Dtsch Z Mund Kiefer Gesichts Chir 1991; 15: 6-15.
14. GROB D. Anticholinesterase intoxication in man and its treatment. Cholinesterases and anticholinesterase agents. In: KOELLE GB, ed. Handbuch der Experimentellen Pharmakologie. Berlin: Springer Verlag, 1963; 990-1027.
15. EMMELIN N. Pharmacology of salivary glands. In: CODE CF, ed. Handbook of physiology. Alimentary canal. Washington, D.C.: American Physiological Society, 1966; 665-678.
16. EMMELIN N. Action of transmitters on the responsiveness of effector cells. Experientia 1965; 21: 57-65.
17. EKSTRÖM J, EMMELIN N. Reinnervation of the denervated parotid gland of the cat. Quart J Exper Physiol 1974; 59: 1-9.
18. JOHNSON JT, FERRETTI GA, NETHERY J, VALDEZ IH, Fox FC, NG D, MUSCOPLAT CC, GALLAGHER SC. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New Engl J Med 1993; 329: 390-395.
19. HAMLAR DD, SCHULLER DE, GAHBAUER RA, BUERKI RA, STAUBUS AE, HALL J, ALTMAN JS, ELZINGA DJ, MARTIN MR. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope 1996; 106: 972-976.